Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 20, 2026

  1. Minor: Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension) Trial completed Provention Bio, a Sanofi CompanyNot specified NCT04598893
  2. Minor: Disease Modifying Therapy Use · Multiple Sclerosis Before, During, and After Pregnancy Trial completed Novartis PharmaceuticalsNot specified NCT07844070
  3. Minor: Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) Trial completed Acorn Biolabs Inc.Not applicable NCT07107841
  4. Minor: SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control Trial completed TCI Co., Ltd.Not applicable NCT07705191
  5. Minor: Using NMN to Improve Embryo Development Capacity Trial completed Sunkaky Medical CooperationNot applicable NCT06629636
  6. Minor: Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX) Trial completed Sight Sciences, Inc.Not applicable NCT06948773
  7. Minor: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft Trial completed Artoss Inc.Not applicable NCT04615260
  8. Minor: Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness Enrollment closed, study ongoing National Cancer Institute (NCI)Phase 1/2 NCT05691491
  9. Minor: Small Nerve Fiber Activity · Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing Trial completed Brooke Army Medical CenterNot applicable NCT06550284
  10. Minor: Methods Used · Coccydynia Trial status changed: Unknown → Completed Ankara Etlik City HospitalNot applicable NCT06653179
  11. Minor: CHOPXE - Analysis of Choriocapillaris Flow Deficits · Pseudoxanthoma Elasticum Trial completed University Hospital, AngersNot applicable NCT07006649
  12. Minor: Stress Hydrocortisone In Pediatric Septic Shock Enrollment closed, study ongoing Jerry ZimmermanPhase 3 NCT03401398
  13. Minor: Pediatric Dose Optimization for Seizures in Emergency Medical Services Trial completed Stanford UniversityPhase 3 NCT05121324
  14. Minor: Poly-L-lactic Acid (PLLA) Injection for Neck Skin Laxity: A Pilot Study Trial status changed: Not Yet Recruiting → Active, Not Recruiting Institute of Dermatology, ThailandNot applicable NCT07689344
  15. Minor: BRAHMS · Bed Rest And HypoMetabolism Study Trial completed Centre National d'Etudes SpatialesNot applicable NCT07499167
  16. Minor: RSC-1255 · Advanced Malignancies Primary completion pushed from Dec 15, 2026 to Mar 16, 2027 RasCal Therapeutics, Inc.Phase 1 NCT04678648
  17. Minor: Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study Enrollment closed, study ongoing Baystate Medical CenterPhase 2 NCT05733767
  18. Minor: Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa Enrollment closed, study ongoing EpicentrePhase 4 NCT06860178
  19. Minor: Intraarticular Tramadol and Tramadol-Dexamethasone on Postoperative Pain After Knee Arthroscopy Trial status changed: Not Yet Recruiting → Active, Not Recruiting Arzu Esen TekeliPhase 4 NCT07064993
  20. Minor: Boost GVAX Pancreas Vaccine With or Without CY · Pancreas Cancer Trial completed Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 NCT01088789
  21. Minor: Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers Primary and study completion pushed from Sep 26, 2026 to Jan 31, 2027 Agomab Spain S.L.U.Phase 1 NCT07672574
  22. Minor: INTERACT Stomach-II Enrollment closed, study ongoing Erasmus Medical CenterPhase 2 NCT07133490
  23. Minor: PIT565 in Relapsed and/or Refractory B-cell Malignancies Primary and study completion pushed from Jan 4, 2027 to May 31, 2027 Novartis PharmaceuticalsPhase 1 NCT05397496
  24. Minor: Administration of MELPIDA to Determine the Safety and Efficacy · Spastic Paraplegia Type 50 Trial completed The Hospital for Sick ChildrenPhase 1 NCT06069687
  25. Minor: IS-free Treg HaploHCT Enrollment closed, study ongoing Dana-Farber Cancer InstitutePhase 1 NCT04678401